HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideo Yoshida Selected Research

alpha-Fetoproteins (alpha-Fetoprotein)

7/2021Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.
3/2019Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
12/2008Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma.
12/2007Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment.
12/2006Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
1/2004Optimal strategy of preoperative transcatheter arterial chemoembolization for hepatoblastoma.
1/2003Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideo Yoshida Research Topics

Disease

36Neoplasms (Cancer)
07/2018 - 07/2002
17Hepatocellular Carcinoma (Hepatoma)
07/2022 - 01/2003
16Squamous Cell Carcinoma of Head and Neck
11/2007 - 07/2002
13Neuroblastoma
10/2020 - 02/2003
11Infections
01/2022 - 02/2002
6Fibrosis (Cirrhosis)
07/2022 - 01/2003
6Thrombosis (Thrombus)
01/2012 - 09/2008
5Pancreaticobiliary Maljunction
06/2016 - 01/2006
5Mouth Neoplasms (Oral Cancer)
07/2005 - 10/2002
4Chronic Hepatitis C
07/2022 - 09/2006
4Hepatitis C
01/2022 - 12/2009
4Biliary Atresia
06/2017 - 08/2011
4Colitis
11/2011 - 09/2008
4Neoplasm Metastasis (Metastasis)
11/2008 - 05/2003
4Lymphatic Metastasis
03/2006 - 11/2003
3Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 01/2004
3Hemorrhage
02/2022 - 03/2011
3Aneurysm (Aneurysms)
02/2021 - 10/2018
3Cysts
06/2016 - 11/2003
3Inflammation (Inflammations)
12/2011 - 11/2008
3Salivary Gland Neoplasms (Salivary Gland Cancer)
10/2004 - 03/2002
2Stroke (Strokes)
02/2022 - 01/2012
2Adenocarcinoma
04/2021 - 11/2002
2Cicatrix (Scar)
02/2021 - 01/2004
2Virus Diseases (Viral Diseases)
06/2020 - 01/2012
2Hypertrophic Pyloric Stenosis
11/2019 - 09/2008
2Disease Progression
08/2018 - 08/2011
2Aortic Dissection
01/2017 - 11/2016
2Dyspepsia (Indigestion)
02/2016 - 11/2007
2Peripheral Arterial Disease
08/2012 - 03/2012
2Intermittent Claudication
08/2012 - 03/2012
2Pancreas Divisum
04/2010 - 01/2004
2Pancreatitis
04/2010 - 03/2008
2Carcinogenesis
07/2009 - 01/2006
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2008 - 02/2007
2Body Weight (Weight, Body)
07/2007 - 07/2007
2Liver Diseases (Liver Disease)
02/2007 - 09/2002
2Head and Neck Neoplasms (Head and Neck Cancer)
09/2005 - 07/2002

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2002
8Antiviral Agents (Antivirals)IBA
07/2022 - 03/2008
8CytokinesIBA
06/2017 - 11/2002
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2021 - 01/2003
5Phosphodiesterase 3 InhibitorsIBA
02/2022 - 03/2011
5InterferonsIBA
07/2021 - 07/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2019 - 11/2002
5Biological ProductsIBA
02/2018 - 05/2005
5phytobacteriomycin (PBM)IBA
06/2016 - 01/2006
5Messenger RNA (mRNA)IBA
12/2015 - 07/2002
5Cyclin-Dependent Kinase Inhibitor p27IBA
09/2005 - 10/2002
4Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
02/2022 - 03/2011
4Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2008
4BilirubinIBA
01/2013 - 11/2007
4Dextrans (Dextran)FDA Link
11/2011 - 09/2008
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
11/2011 - 09/2008
4Coloring Agents (Dyes)IBA
11/2011 - 09/2008
4AutoantibodiesIBA
12/2008 - 08/2002
3AlbuminsIBA
07/2022 - 09/2008
3Serum AlbuminIBA
06/2020 - 02/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 09/2002
3InterleukinsIBA
03/2019 - 11/2002
3Tumor Biomarkers (Tumor Markers)IBA
12/2015 - 12/2006
3LigandsIBA
12/2011 - 07/2007
3pristane (pristan)IBA
12/2008 - 08/2002
3Therapeutic UsesIBA
11/2008 - 05/2005
3Chemokine CXCL12IBA
07/2007 - 11/2003
3Antineoplastic Agents (Antineoplastics)IBA
07/2007 - 08/2004
3S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
09/2005 - 05/2005
3PicibanilIBA
10/2004 - 11/2002
2lenvatinibIBA
05/2021 - 06/2020
2Interleukin-12 (IL 12)IBA
03/2019 - 11/2002
2Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2016 - 07/2004
2Oxygen (Dioxygen)IBA
02/2016 - 10/2004
2Cilostazol (Pletal)FDA LinkGeneric
03/2012 - 01/2012
2Double-Stranded RNA (RNA, Double Stranded)IBA
01/2012 - 07/2009
2Pharmaceutical PreparationsIBA
01/2012 - 03/2003
2Interleukin-1beta (Interleukin 1 beta)IBA
12/2010 - 01/2003
2Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2009 - 05/2005
2lentil lectinIBA
12/2008 - 12/2006
2acarboxyprothrombin (PIVKA)IBA
12/2008 - 12/2006
2Protein CIBA
11/2008 - 09/2008
2Lamivudine (Epivir)FDA Link
03/2008 - 03/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2007 - 12/2005
2Carrier Proteins (Binding Protein)IBA
03/2006 - 09/2005
2Interleukin-8 (Interleukin 8)IBA
12/2005 - 07/2005

Therapy/Procedure

25Therapeutics
07/2022 - 01/2003
6Drug Therapy (Chemotherapy)
07/2015 - 01/2004
4Radiofrequency Ablation
01/2009 - 12/2007
4Radiotherapy
11/2007 - 08/2004
3Stents
10/2020 - 02/2003
3Liver Transplantation
12/2009 - 03/2007
2Aftercare (After-Treatment)
01/2022 - 12/2015
2Renal Dialysis (Hemodialysis)
06/2020 - 08/2018
2Pyloromyotomy
11/2019 - 09/2008
2Sternotomy
06/2017 - 01/2017
2Thoracotomy
06/2017 - 01/2017
2Endovascular Aneurysm Repair
01/2017 - 08/2014
2Intravenous Infusions
06/2016 - 01/2003
2Ligation
08/2012 - 12/2006
2Oral Administration
08/2012 - 03/2012
2Transplantation
03/2007 - 12/2005